<DOC>
	<DOCNO>NCT02176746</DOCNO>
	<brief_summary>Most study cancer stem cell ( CSC ) involve inoculation cell human tumor immunosuppressed mouse , prevent assessment immunologic interaction effect CSCs . In study , investigator examine vaccination effect produce CSC-enriched population histologically distinct murine tumor inoculation different syngeneic immunocompetent host . Enriched CSCs immunogenic effective antigen source unselected tumor cell induce protective antitumor immunity.Immune sera CSC-vaccinated host contain high level IgG bound CSCs , result CSC lysis presence complement.CTLs generate peripheral blood mononuclear cell splenocytes harvest CSC-vaccinated host capable kill CSCs vitro . Mechanistic investigation establish CSC-primed antibody T cell capable selective target CSCs confer anti-tumor immunity .</brief_summary>
	<brief_title>A Phase I/II Study Active Immunotherapy With Cancer Stem Cells Vaccine Colorectal Cancer</brief_title>
	<detailed_description>To assess feasibility generate CSC-loaded DC vaccine clinical use , investigator harvest peripheral blood tumor specimen patient colorectal cancer . The investigator purify T , B cell generate DCs PBMCs colorectal cancer patient.On hand , investigator isolate ALDHhigh ALDHlow tumor cell tumor specimen colorectal cancer patient use similar protocol investigator report . Aim 1 : To demonstrate , vitro , relative cellular anti-colorectal cancer CSC immunity induce colorectal cancer CSC-DC prim cytotoxic T cell . Aim 2 : To determine , vitro , specific bind lysis colorectal cancer CSCs antibody produce purified B cell PBMCs stimulate colorectal cancer CSC-DC .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Age:18 2 . Performance status : Karnofsky 70100 % 3 . Life expectancy : Greater 6 month 4 . Hematopoietic : Absolute neutrophil count least 1000/mm 3 , Hemoglobin least 9 g/dL , Platelet count least 100,000/mm^3 5 . Hepatic : Bilirubin le 2.0 mg/dL No chronic acute hepatic disease Renal : Creatinine le 2.5 mg/dL 6 . Cardiovascular : No chronic acute cardiac disease ( New York Heart Association class III IV ) 7 . Pulmonary : No chronic acute pulmonary illness asthma chronic obstructive pulmonary disease 1 . Patients receive anticoagulation therapy . 2 . Patients receive investigational agent . 3 . Patients test positive Hepatitis B virus , Hepatitis C virus HIV . 4、level 3 hypertension ; 5、severe coronary disease ; 6、 myelosuppression ; 7、 respiratory disease ; 8、 brain metastasis ; 9、 chronic infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>